Cancer Heterogeneity and Plasticity ISSN 2818-7792

Xiaoqi Liu  PhD

Chair and Professor, Department of Toxicology and Cancer Biology, Lucille P. Markey Endowed Chair in Oncology Research, University of Kentucky College of Medicine, USA
Research Interests: Cancer biology; signaling transduction; cell cycle regulation; DNA damage repair; therapy resistance; anti-cancer drugs; prostate cancer; pancreatic cancer; melanoma; lung cancer
E-Mail | Website

As PI or co-Investigator on several ACS-, NSF-, DoD and NIH-funded grants, I laid the groundwork for the proposed research by providing key preliminary data. I received my Ph.D. in Dr. Michael Smerdon’s lab in Washington State University by working on DNA repair of UV-induced DNA damage. I did my post-doctoral training with Dr. Raymond Erikson at Harvard University by working on signal transduction in mitosis, particular polo-like kinase 1 (Plk1). I started my independent laboratory at Purdue University in 2006 by focusing on understanding the regulation of Plk1 in cancer cells. As an Assistant Professor, I have made a series of contributions to the scientific community: (1) Identification of Chk1 and MK2 as two upstream regulators of Plk1. (2) Identification of Plk1 substrates in various cellular processes. In the second stage of my independent career, I aimed to understand how Plk1 directly contributes to oncogenesis by inactivation of tumor suppressors. I have established my reputation as one of major contributors of the Plk1 field over the last 20 years (Liu et al., Translational Oncology, 2015).

About Us Journals Join Us Submit Fees Contact